Endowment helps entrepreneurial U-M students to go from idea to biz

There's little doubt that the university is an incubator for big ideas. But how many of those ideas can be translated into business? And what is the process for doing that? Tim Mayleben, CEO of biotech firm Aastrom Biosciences and former COO of Esperion Therapeutics, decided to help that process along. Excerpt: "“There’s this gap between ‘I have this cool idea,’ which is not a business, but it’s a cool idea, it’s a kernel of a business, but how do you transfer into the framework of a business which you could then go do a feasibility study on to see if it’s worth doing?” said Tim Faley, managing director of the Zell Lurie Institute." Read the rest here.